Itaconate boosts malaria via induction of PD-L1
- PMID: 38447526
- DOI: 10.1016/j.cmet.2024.02.005
Itaconate boosts malaria via induction of PD-L1
Abstract
The Krebs-cycle-derived metabolite itaconate has been shown to be immunomodulatory, targeting multiple processes in macrophages. Ramalho et al. reveal an additional role for itaconate in malaria.1Plasmodium Chabaudi induces itaconate in dendritic cells (DCs), leading to programmed death-ligand 1 (PD-L1) induction. This suppresses CD8+ T cells, important for host defense against malaria, thereby promoting parasitemia.
Copyright © 2024. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Itaconate impairs immune control of Plasmodium by enhancing mtDNA-mediated PD-L1 expression in monocyte-derived dendritic cells.Cell Metab. 2024 Mar 5;36(3):484-497.e6. doi: 10.1016/j.cmet.2024.01.008. Epub 2024 Feb 6. Cell Metab. 2024. PMID: 38325373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
